These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 27150938

  • 21. Impact of formulary restrictions on medication use and costs.
    Shen X, Stuart BC, Powers CA, Tom SE, Magder LS, Perfetto EM.
    Am J Manag Care; 2017 Aug 01; 23(8):e265-e274. PubMed ID: 29087150
    [Abstract] [Full Text] [Related]

  • 22. Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement.
    Duru OK, Edgington S, Mangione C, Turk N, Tseng CH, Kimbro L, Ettner S.
    Pharmacotherapy; 2014 Dec 01; 34(12):1230-8. PubMed ID: 25314343
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
    Clark B, DuChane J, Hou J, Rubinstein E, McMurray J, Duncan I.
    J Manag Care Pharm; 2014 Feb 01; 20(2):141-50. PubMed ID: 24456315
    [Abstract] [Full Text] [Related]

  • 24. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.
    Duru OK, Mangione CM, Hsu J, Steers WN, Quiter E, Turk N, Ettner SL, Schmittdiel JA, Tseng CW.
    J Am Geriatr Soc; 2010 May 01; 58(5):822-8. PubMed ID: 20406312
    [Abstract] [Full Text] [Related]

  • 25. Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes.
    Glynn A, Hernandez I, Roberts ET.
    Health Serv Res; 2022 Oct 01; 57(5):1136-1144. PubMed ID: 35430735
    [Abstract] [Full Text] [Related]

  • 26. How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction.
    Stuart B, Davidoff A, Erten M, Gottlieb SS, Dai M, Shaffer T, Zuckerman IH, Simoni-Wastila L, Bryant-Comstock L, Shenolikar R.
    Health Serv Res; 2013 Dec 01; 48(6 Pt 1):1960-77. PubMed ID: 23742013
    [Abstract] [Full Text] [Related]

  • 27. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
    Stuart B, Simoni-Wastila L, Yin X, Davidoff A, Zuckerman IH, Doshi J.
    Med Care; 2011 May 01; 49(5):511-5. PubMed ID: 21422956
    [Abstract] [Full Text] [Related]

  • 28. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
    Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP.
    Med Care; 2010 May 01; 48(5):409-17. PubMed ID: 20393360
    [Abstract] [Full Text] [Related]

  • 29. Changes in Medication Management After a Diagnosis of Cancer Among Medicare Beneficiaries With Diabetes.
    Stuart BC, Davidoff AJ, Erten MZ.
    J Oncol Pract; 2015 Nov 01; 11(6):429-34. PubMed ID: 26105669
    [Abstract] [Full Text] [Related]

  • 30. Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures?
    Ta JT, Erickson SC, Qiu WA, Patel BV.
    J Manag Care Spec Pharm; 2016 Jul 01; 22(7):787-95. PubMed ID: 27348279
    [Abstract] [Full Text] [Related]

  • 31. Impact of medicare part D plan features on use of generic drugs.
    Tang Y, Gellad WF, Men A, Donohue JM.
    Med Care; 2014 Jun 01; 52(6):541-8. PubMed ID: 24824538
    [Abstract] [Full Text] [Related]

  • 32. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.
    Zhang L, Zakharyan A, Stockl KM, Harada AS, Curtis BS, Solow BK.
    J Med Econ; 2011 Jun 01; 14(5):562-7. PubMed ID: 21728913
    [Abstract] [Full Text] [Related]

  • 33. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study.
    Duru OK, Ettner SL, Turk N, Mangione CM, Brown AF, Fu J, Simien L, Tseng CW.
    J Gen Intern Med; 2014 Jan 01; 29(1):230-6. PubMed ID: 23975059
    [Abstract] [Full Text] [Related]

  • 34. Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis.
    Tseng CW, Dudley RA, Chen R, Walensky RP.
    JAMA Netw Open; 2020 Apr 01; 3(4):e202739. PubMed ID: 32286656
    [Abstract] [Full Text] [Related]

  • 35. Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006.
    Li P, Schwartz JS, Doshi JA.
    J Am Heart Assoc; 2016 Nov 11; 5(11):. PubMed ID: 27836822
    [Abstract] [Full Text] [Related]

  • 36. How do seniors respond to 100% cost-sharing for prescription drugs? Quality of the evidence underlying opinions about the Medicare Part D coverage gap.
    Fairman KA, Curtiss FR.
    J Manag Care Pharm; 2011 Jun 11; 17(5):382-92. PubMed ID: 21657807
    [Abstract] [Full Text] [Related]

  • 37. Affordability and adherence gains for Medicare Part D low-income subsidy recipients when low-income subsidy benefits expanded in 2024.
    Stuart BC, Loh FE, Dougherty JS.
    J Manag Care Spec Pharm; 2024 Jul 11; 30(7):728-735. PubMed ID: 38950158
    [Abstract] [Full Text] [Related]

  • 38. Generic alendronate use among Medicare beneficiaries: are Part D data complete?
    Yun H, Curtis JR, Saag K, Kilgore M, Muntner P, Smith W, Matthews R, Wright N, Morrisey MA, Delzell E.
    Pharmacoepidemiol Drug Saf; 2013 Jan 11; 22(1):55-63. PubMed ID: 23135758
    [Abstract] [Full Text] [Related]

  • 39. Differential Effects by Mental Health Status of Filling the Medicare Part D Coverage Gap.
    Liu J, Zhang Y, Kaplan CM.
    Med Care; 2022 Feb 01; 60(2):133-139. PubMed ID: 35030562
    [Abstract] [Full Text] [Related]

  • 40. Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.
    Kuye IO, Frank RG, McWilliams JM.
    JAMA Intern Med; 2013 Jun 24; 173(12):1100-7. PubMed ID: 23649604
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.